Healthcare -
Biotechnology - NASDAQ - US
$ 23.0
-0.611 %
$ 676 M
Market Cap
-4.44
P/E
ANAB - CAPITAL EXPENDITURES
Capital Expenditures ANAB - AnaptysBio, Inc.
-358 K
LAST VALUE
-0.00%
2 YEAR CAGR
14.96%
5 YEAR CAGR
-9.46%
10 YEAR CAGR